Blog Read the latest perspectives from our team of subject matter experts and others 4 Ways CROs Can Ensure a Bright Future for PharmaAs pharmaceutical companies turn to CROs (Clinical Research Organizations) for trial design and technology, there are new opportunities emerging with healthcare data intelligence that can help ensure a bright future… Continue reading → Read the article Post Topics:Artificial Intelligence Commercialization Diversity & Inclusion Drug Development KOL Engagement Medical Devices Provider Data Research Post Industries:Commercialization Medical Devices Payors Pharmaceutical & Biotechnology Provider Data Research Diversity & InclusionDrug Development3 Ways CROs Can Expedite Clinical Trial Site SuccessClinical Research Organizations (CROs) play an important role in the success of clinical trials. They provide crucial resources, processes, and strategies to ensure that trials are conducted with the… Continue reading → Read the articleno KOL EngagementLet’s Get Personal: Four Benefits to Omnichannel StrategiesWith the proliferation of digital media, marketing in the healthcare industry has shifted from traditional tactics to an omnichannel approach. Omnichannel engagement for physician marketing is a powerful tool… Continue reading → Read the articleno KOL EngagementNurses: The Unsung Heroes in Pharma and Biotech for Health Equity and Medication AdherenceHealthcare providers are often the first line of defense in ensuring that people receive the medical treatment they need. But nurses are often overlooked as a solution to addressing health… Continue reading → Read the articleno Diversity & InclusionKOL EngagementFour Ideas for Pharma to Maximize the Influence of Digital Opinion Leaders in MedicinePharmaceutical companies have long recognized the importance of engaging key opinion leaders (KOLs) to gain insight and support for clinical research, drug development, and medical education. With the rise… Continue reading → Read the articleno Diversity & InclusionDrug DevelopmentData Networks & Guiding Clinical Trials – Six Metrics for Powering Trials to Reach Vulnerable Patient PopulationsFor clinical operations and development clinical feasibility teams, diversity equity and inclusion and health equity leaders, as well as health economics and outcomes research (HEOR) teams, it is essential to… Continue reading → Read the articleno CommercializationMedical DevicesQuality vs Quantity: Strategies For Device Manufacturers to Succeed in the Current MarketplaceThe United States devotes roughly $200 billion to national health expenditures on medical devices every year. In fact, the global medical devices market is projected to grow from $495.46 billion… Continue reading → Read the articleno‹123456›»
